Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonism

Pharmacological Research(2022)10.1016/j.phrs.2022.106338Source: DataRank Database

Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonism is a research paper published in Pharmacological Research (2022). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 1.41)OA: greenTopics (47)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Silvia Pontis ORCID,Natalia Realini ORCID,Alexa Torrens ORCID,Faizy Ahmed,Francesca Assogna ORCID

Live enrichment

PubMed:35781057 PMC:PMC9733952 OpenAlex:https://openalex.org/W4283723699

Arizona Biomedical Research Commission

Grant: 05–901

Arizona Biomedical Research Commission

Grant: 1001

Arizona Biomedical Research Commission

Grant: 4001

Ministero della Salute

Grant: RF-2013–02359074

NIH

Grant: R01AG065329

National Institute of Neurological Disorders and Stroke

Grant: U24 NS072026

National Institute on Aging

Grant: 211002

National Institute on Aging

Grant: P30 AG19610

NIA NIH HHS

Grant: RF1 AG065329

NIA NIH HHS

Grant: P30 AG019610

Michael J. Fox Foundation for Parkinson's Research

FWCI

1.41

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9733952

publisherhttps://api.elsevier.com/content/article/PII:S1043661822002833?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1043661822002833?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.phrs.2022.106338

Fields of Study

Parkinson's Disease Mechanisms and TreatmentsCannabis and Cannabinoid ResearchRestless Legs Syndrome Research1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineAmidohydrolasesAnimalsDisease Models, AnimalDopamineDopaminergic NeuronsEnzyme InhibitorsHumansMiceNerve DegenerationNeuroblastomaOxidopamineParkinsonian Disorders

MeSH Terms

AmidohydrolasesAnimalsDisease Models, AnimalDopamineEnzyme InhibitorsHumansNerve DegenerationNeuroblastoma1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineOxidopamineParkinsonian DisordersMiceDopaminergic Neurons

Keywords

MPTPPalmitoylethanolamideDopaminergicNeuroprotectionDopamineParkinsonismSubstantia nigraChemistryInternal medicinePharmacologyEndocrinologyAgonistMedicineReceptorNeurodegenerationParkinson's DiseaseneuroinflammationN-acylethanolamine Acid Amidase

Sustainable Development Goals

SDG 0: Good health and well-being

Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonism

FAIR Checklist

Authors (11)

Funding (11 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)